Covered recipient · General Payments record
RANDALL G TRUDELL
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$79,148.77
- Reported across 493 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $737.13 | 24 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| EMD Serono, Inc. | $149.35 | 1 |
| Alexion Pharmaceuticals, Inc. | $139.96 | 3 |
| ABBVIE INC. | $131.29 | 5 |
| Amgen Inc. | $61.06 | 3 |
| Celgene Corporation | $52.95 | 3 |
| PFIZER INC. | $52.32 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $50.86 | 2 |
| Biogen, Inc. | $50.04 | 2 |
| Neurelis, Inc. | $27.45 | 1 |
| HOSPIRA, INC. | $21.85 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $26.53 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106246467 | CMS |
| ABBVIE INC. | $27.72 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106246469 | CMS |
| ABBVIE INC. | $25.58 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106246471 | CMS |
| ABBVIE INC. | $19.41 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106246473 | CMS |
| ABBVIE INC. | $32.05 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106246475 | CMS |
| Alexion Pharmaceuticals, Inc. | $96.30 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1094016140 | CMS |
| Alexion Pharmaceuticals, Inc. | $21.84 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093988336 | CMS |
| Alexion Pharmaceuticals, Inc. | $21.82 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093987777 | CMS |
| Amgen Inc. | $19.63 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116185144 | CMS |
| Amgen Inc. | $19.73 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116185148 | CMS |
| Amgen Inc. | $21.70 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116185151 | CMS |
| Biogen, Inc. | $21.40 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104860032 | CMS |
| Biogen, Inc. | $28.64 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104807603 | CMS |
| Celgene Corporation | $17.88 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101147357 | CMS |
| Celgene Corporation | $17.61 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101147363 | CMS |
| Celgene Corporation | $17.46 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101147369 | CMS |
| EMD Serono, Inc. | $149.35 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120215008 | CMS |
| HOSPIRA, INC. | $21.85 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131856222 | CMS |
| Neurelis, Inc. | $27.45 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145657305 | CMS |
| Novartis Pharmaceuticals Corporation | $26.26 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087346386 | CMS |
| Novartis Pharmaceuticals Corporation | $24.60 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087346400 | CMS |
| PFIZER INC. | $19.49 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131687414 | CMS |
| PFIZER INC. | $18.22 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131837738 | CMS |
| PFIZER INC. | $14.61 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131927016 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.